Healthcare and Distribution Services - Audon Trap & Partners

More documents

Recommendations

Info

Generic Drugs Eu Yan Sang (Hong Kong) Jacobson Medical Advisor to seller Ltd. (Hong Kong) Ltd. Eu Yan Sang (Hong Kong) Ltd. is a traditional Chinese medicine group listed in Singapore (Stock code: E02). The group was looking to divest its subsidiary as a non-core business asset. Eu Yan Sang approached Quam Capital Ltd. to sell its Hong Kong generic manufacturing arm. Quam set up an auction process and sold the company to Hong Kong private company Jacobson Medical (Hong Kong) Ltd. Hong Kong Pharmaceutical Financial Advisor on debt restructuring, Holdings Ltd. capital restructuring and reorganisation Hong Kong Pharmaceutical Holdings Ltd. is a wholesaler and retailer of Chinese medicine, health products and other medicine. The company had been suffering losses and relying on loans to finance its business operations. Quam Capital Ltd. was appointed to advise Hong Kong Pharmaceutical with regards to its capital restructuring, debt restructuring and capital reorganisation. Quam Securities Co. Ltd. also acted as the underwriter in the company’s issue of new shares. Jiangxi Jin Shui Kang Wanji Pharmaceutical Advisor to buyer Pha Co. Ltd. Holdings Ltd. Wanji Pharmaceutical Holdings Ltd. is a healthcare solutions company and medical equipment distributor listed in Hong Kong. Jiangxi Jin Shui Kang Pha Co. Ltd. is a Chinese medicine manufacturer based in mainland China. Through the acquisition of a majority stake in Jiangxi Jin Shui, Wanji was able to expand its medical and healthcare business in order to capitalise on the growth opportunities in the industry. Quam Capital Ltd. was appointed by Wanji to advise on this transaction. M&A International Inc. member firm: Quam Capital Limited Quam Capital Limited Quam Capital Limited 20
Generic Drugs Laboratorios Rider S.A. Synthon Holding B.V. Advisor to seller IB Partners acted as exclusive financial advisor to the shareholders of Laboratorios Rider S.A. (“Rider”) on the origination, execution, and structuring of the transaction. Holland Corporate Finance was key in identifying Synthon, the purchaser. IB Partners ran a global private competitive auction process with participation of a full range of pharmaceutical companies. The shareholders of Rider and Synthon Holding BV (“Synthon”) reached an agreement in which Synthon acquired Rider, which continues to operate under the same name. Rider is a Chilean company specializing in the manufacture and distribution of pharmaceutical products, OTC drugs, and cosmetics, both under its own brands as well as licensed brands. Synthon is a Netherlands-based company specializing in generic drugs, hybrids, and biotechnology products; it has developed more than 500 patents in 20 countries which are licensed by pharmaceutical companies worldwide. Merck Pharmaceutical Ltd. Europharm Laboratories Advisor to buyer Co. Ltd. Europharm Laboratories Co. Ltd., a private company, is one of the leading pharmaceutical manufacturers in Hong Kong. Merck Pharmaceutical Ltd. is a global pharmaceuticals and chemicals group with a worldwide presence including the Peoples’ Republic of China. Quam Capital Ltd. was appointed by Europharm in its acquisition of the China generic drug manufacturing division of Merck. Quam identified and introduced the target company to Europharm. As a result of this acquisition Europharm has been able to significantly increase its China generic drug manufacturing capability. Pangeo Pharma, Inc. Marketing/Licensing Advisor to Management Pangeo Pharma, now part of Pharmascience, Inc., is a specialty Canadian Pharmaceutical company involved in Consumer Health products and Private Labels. Pangeo was looking to develop relationships with several Japanese Pharmaceutical companies to license and market products for treatment of certain Cardio-Vascular conditions. Morgen, Evan & Company assisted Pangeo in setting up these relationships with various Japanese Pharmaceutical companies. M&A International Inc. member firm: IB Partners Quam Capital Limited Morgen, Evan & Company, Inc. 21
Page 1 and 2: M&A International Inc. Healthcare G
Page 3 and 4: Welcome Remarks Dear Healthcare Col
Page 5 and 6: Healthcare group specialists Group
Page 7 and 8: Selected transactions Target Buyer
Page 9 and 10: Selected transactions Target Buyer
Page 11 and 12: Animal Health Antec International D
Page 13 and 14: Biotechnology Best Medical Internat
Page 15 and 16: CMOs/CROs MDS Panlabs, inc. CDIB Bi
Page 17 and 18: Diagnostics DDD Diagnostic Advisor
Page 19: Generic Drugs C.B. Fleet Co. Inc./
Page 23 and 24: Generic Drugs Zentiva Following com
Page 25 and 26: Healthcare Information Systems MDIn
Page 27 and 28: Healthcare and Distribution Service
Page 33 and 34: Hospitals/Home Care/Nursing Managem
Page 35 and 36: Hospitals/Home Care/Nursing Managem
Page 37 and 38: Medical Devices and Equipment Bio-M
Page 39 and 40: Medical Devices and Equipment MediG
Page 41 and 42: Pharmaceuticals and Drug Delivery A
Page 43 and 44: Pharmaceuticals and Drug Delivery S
Page 45 and 46: Specialty Pharma and Drug Discovery
Page 47 and 48: H E A L T H C A R E G R O U P www.m

Healthcare and Distribution Services - Audon Trap & Partners

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?